ABT Abbott Laboratories
- 110.940
- +1.050+0.96%
- 110.760
- -0.180-0.16%
Abbott Laboratories News
Abbott Laboratories | 10-Q: Q2 2024 Earnings Report
Abbott Laboratories | 8-K: Abbott Reports Second-Quarter 2024 Results and Raises Full-Year Guidance
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Morrone Louis H.
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Gonzalez Patricia Paola
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Alpern Robert J
Abbott Laboratories | 11-K: Annual report of employee stock purchase, savings and similar plans (and amendment thereto)
Abbott Laboratories | SD: Specialized disclosure report
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Funck, Jr. Robert E.
Abbott Laboratories | 144: Notice of proposed sale of securities pursuant to Rule 144
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Officer Earnhardt Lisa D
Abbott Laboratories | 144: Notice of proposed sale of securities pursuant to Rule 144
Abbott Laboratories | 10-Q: Q1 2024 Earnings Report
Abbott Laboratories | 8-K: Current report
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Stratton John G
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director STARKS DANIEL J
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director Roman Michael F
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director O'Grady Michael
Abbott Laboratories | 4: Statement of changes in beneficial ownership of securities-Director McKinstry Nancy
Analysis
Price Target
No Data
